Share this article Share this article ROCKVILLE, Md., Feb. 1, 2021 /PRNewswire/ -- Since November of 2020, scientist and the medical community have been following three new variants of SARS-CoV-2 with great interest and concern. 1,2 The B.1.1.7 variant discovered in the United Kingdom, the South African and the Brazilian variants have all found their way to the United States and based on some reports, may be 50% more transmissible than the current strain of SARS-CoV-2. 3 Cellex qSARS-Cov-2 Antigen Rapid Test from Spartan Medical Inc. The Cellex qSARS-CoV-2 Antigen Rapid Test manufactured by Cellex, and available to local, state, and federal governments through a partnership between HealthDatix and Spartan Medical, should not be affected by the new B.1.1.7 variant nor the other N501Y variant strains discovered in South Africa and Brazil. Dr. Li, CEO of Cellex said,